Brawn biotech Limited has submitted its quarterly compliance certificate to BSE Limited, fulfilling regulatory requirements under SEBI (Depositories and Participants) Regulations, 2018. The certificate covers the quarter ended March 31, 2026, and was filed on April 7, 2026, by Company Secretary and Compliance Officer Priyanka Sharma.

Regulatory Compliance Details

The submission relates to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, which mandates quarterly compliance reporting for dematerialisation processes. The certificate was prepared by RCMC Share Registry Private Limited, serving as the company's registrar and share transfer agent.

Dematerialisation Process Confirmation

RCMC Share Registry Private Limited confirmed that all securities received from depository participants for dematerialisation during the quarter ended March 31, 2026 were properly processed. The registrar verified that securities comprised in the certificates have been listed on stock exchanges where the company's earlier issued securities are already listed.

The compliance certificate specifically confirms several key operational aspects:

• Securities received for dematerialisation were confirmed to depositories
• Security certificates were mutilated and cancelled after due verification
• Depository names were substituted in the register of members as registered owners
• All processes were completed within the prescribed 15-day timeframe

Company Information

Brawn Biotech Limited operates with its registered office located at C-64, Lajpat Nagar-1, First Floor, New Delhi-110024. The company's manufacturing facility is situated at Plot No.44, Pace City-1, Sector 37, Near Hero Honda Chowk, Gurugram, Haryana. The company's shares are listed on BSE with scrip code 530207 and scrip ID BRAWN.

Regulatory Framework

The SEBI (Depositories and Participants) Regulations, 2018 require companies to maintain proper records and processes for dematerialisation of securities. Regulation 74(5) specifically mandates quarterly certification to ensure transparency and compliance in the depository system. This regulatory framework helps maintain investor confidence and ensures proper handling of securities in electronic form.

Brawn Biotech Limited announced the appointment of new auditors following its board meeting held on March 25, 2026. The company has strengthened its governance framework by appointing key auditing professionals for the financial year 2025-26, in compliance with regulatory requirements.

Board Meeting Outcomes

The board meeting, which commenced at 11:00 A.M. and concluded at 11:30 A.M., addressed critical auditing appointments based on recommendations from the Audit Committee. The decisions were made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Secretarial Auditor Appointment

The company appointed Mr. Viney, a practicing Company Secretary, as its Secretarial Auditor for the financial year 2025-26. Mr. Viney holds Certificate of Practice number 28263 and is an Associate Member of the Institute of Company Secretaries of India (ICSI).

Mr. Viney brings extensive expertise in corporate laws, securities laws, and compliance management. His professional experience includes handling secretarial audits, corporate restructuring, due diligence, FEMA compliances, and SEBI-related matters including LODR and PIT Regulations. He has assisted various listed and unlisted companies in ensuring statutory compliance, drafting corporate documents, and representing clients before regulatory authorities.

Internal Auditor Appointment

Brawn Biotech Limited also appointed M/s Sahil Pasricha & Associates as Internal Auditors for the financial year 2025-26. The firm, registered with FRN: 026379N, is a chartered accountant firm offering comprehensive auditing and consultancy services.

The firm provides a full range of services including:

• Audit under Companies Act
• Income Tax and GST Audit
• Delhi VAT Act compliance
• Internal Audit services
• Taxation consultancy covering Income Tax, GST, Sales Tax, and Service Tax
• Company Law matters and Labour Laws compliance

Regulatory Compliance

Both appointments were made in accordance with SEBI regulations and the Master Circular vide no. SEBI/HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026. The appointments reflect the company's commitment to maintaining robust governance standards and regulatory compliance for the financial year 2025-26.